J
Joshua D. Duncan
Researcher at University of Nottingham
Publications - 6
Citations - 92
Joshua D. Duncan is an academic researcher from University of Nottingham. The author has contributed to research in topics: Adsorption & Vaccination. The author has an hindex of 3, co-authored 5 publications receiving 37 citations. Previous affiliations of Joshua D. Duncan include Nottingham University Hospitals NHS Trust & Health Science University.
Papers
More filters
Journal ArticleDOI
Hepatitis C Virus Vaccine: Challenges and Prospects.
Joshua D. Duncan,Richard A. Urbanowicz,Richard A. Urbanowicz,Alexander W. Tarr,Alexander W. Tarr,Jonathan K. Ball,Jonathan K. Ball +6 more
TL;DR: The challenges facing HCV vaccine design are discussed and the most recent and promising candidates being investigated are discussed.
Journal ArticleDOI
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection.
Richard A. Urbanowicz,Theocharis Tsoleridis,Theocharis Tsoleridis,Hannah J. Jackson,Lola Cusin,Joshua D. Duncan,Joshua D. Duncan,Joseph G. Chappell,Joseph G. Chappell,Alexander W. Tarr,Alexander W. Tarr,Jessica Nightingale,Jessica Nightingale,Jessica Nightingale,Alan Norrish,Alan Norrish,Adeel Ikram,Adeel Ikram,Ben A Marson,Ben A Marson,Simon Craxford,Anthony Kelly,Guruprasad P. Aithal,Guruprasad P. Aithal,Amrita Vijay,Patrick J. Tighe,Jonathan K. Ball,Jonathan K. Ball,Ana M. Valdes,Benjamin J Ollivere +29 more
TL;DR: In this paper, the impact of prior infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the response to vaccination is investigated, and it is shown that additional vaccine boosts may be beneficial in improving immune responses against future variants of concern.
Journal ArticleDOI
Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.
Federico Napolitano,Rossella Merone,Adele Abbate,Virginia Ammendola,Emma Horncastle,Francesca Lanzaro,Marialuisa Esposito,Alessandra Maria Contino,Roberta Sbrocchi,Andrea Sommella,Joshua D. Duncan,Joseph Hinds,Richard A. Urbanowicz,Armin Lahm,Stefano Colloca,Antonella Folgori,Jonathan K. Ball,Alfredo Nicosia,Benjamin Wizel,Stefania Capone,Alessandra Vitelli +20 more
TL;DR: It is demonstrated that one dose of a commercial rabies vaccine effectively boosts the neutralizing antibody responses induced by ChAd155-RG in vaccinated monkeys, showing the compatibility of the novel vectored vaccine with the current post-exposure prophylaxis in the event of rabies virus exposure.
Journal ArticleDOI
Polymer microarrays rapidly identify competitive adsorbents of virus-like particles.
Andrew J. Blok,Pratik Gurnani,Alex Xenopoulos,Laurence Burroughs,Joshua D. Duncan,Richard A. Urbanowicz,Theocharis Tsoleridis,Helena Müller-Kräuter,Thomas Strecker,Jonathan K. Ball,Cameron Alexander,Morgan R. Alexander +11 more
TL;DR: An adaption of a polymer microarray method for screening bacterial-surface interactions allows for the screening of polymers for desirable material-virion interactions and provides the first step in the development of a method for the discovery of novel materials with promise for viral binding.
Posted ContentDOI
Polymer Microarrays Rapidly Identify Competitive Adsorbents of Virus-like Particles (VLPs)
Andrew J. Blok,Pratik Gurnani,Alex Xenopoulos,Laurence Burroughs,Joshua D. Duncan,Richard A. Urbanowicz,Theocharis Tsoleridis,Helena Müller,Thomas Strecker,Jonathan K. Ball,Cameron Alexander,Morgan R. Alexander +11 more
TL;DR: In this article, an adaption of polymer micro array method for screening bacterial-surface interactions allows for screening of polymers for desirable material-viron interactions, and the first step in the development of a method for discovery of novel materials with promise for viral binding, with the next being development of this method to assess absolute viral adsorption and assessment of the attenuation of the activity of live virus which would be part of a material scale up step carried out in biological laboratory safety level 3 facilities and the use of more complex media to represent biological fluids.